ADRX
ADARx Pharmaceuticals, Inc.
There isn't enough reported data to score ADRX yet.
ADRX Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Unavailable | |
| Unavailable | |
| Unavailable |
There isn't enough reported data to rate ADRX's fundamentals.
ADRX PE Valuation
ADRX has no meaningful PE right now: it lost money over the past year.
ADRX Forward outlook
There aren't enough analyst estimates for ADRX to show an outlook.
ADRX Earnings Per Share
ADRX Quarterly Revenue
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -1451% | N/A |
ADRX Free Cash Flow
ADRX Total Shares
ADRX Net Leverage
ADRX's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ADRX Weekly Momentum
As of the close on Nov 12, 2026: $14.91.
ADRX PE vs Healthcare Sector
ADRX has no meaningful PE right now: it lost money over the past year.
ADRX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $17.0 | 12% below |
ADRX is in a downtrend: it's below all one of its weekly moving averages, and 12% below its 8-week average.
ADRX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2026 YTD | $19.4 | $14.9 | -23% |
It's down 23% so far in 2026.